Cargando…

Platform process for production of monoclonal antibodies for research purposes – improvement option

Detalles Bibliográficos
Autores principales:	Petersen, Joern Meidahl, Kristensen, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285018/ https://www.ncbi.nlm.nih.gov/pubmed/22373264 http://dx.doi.org/10.1186/1753-6561-5-S8-P44

Ejemplares similares

Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
por: Landauer, Karlheinz, et al.
Publicado: (2011)

Development and fine-tuning of a scale down model for process characterization studies of a monoclonal antibody upstream production process
por: Harmsen, Mareike, et al.
Publicado: (2011)

Use of Micro Bioreactor systems to streamline cell line evaluation and upstream process development for monoclonal antibody production
por: Warr, Steve R C, et al.
Publicado: (2011)

Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
por: Diekmann, Sonja, et al.
Publicado: (2011)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Preliminary evaluation of microcarrier culture for growth and monoclonal antibody production of CHO-K1 cells
por: Rodrigues, M Elisa, et al.
Publicado: (2011)

Increasing antibody yield and modulating final product quality using the Freedom(TM) CHO-S(TM) production platform
por: Sabourin, Michelle, et al.
Publicado: (2011)

Characterization of binding interactions in solution between β-2-glycoprotein I and monoclonal antibodies
por: Heegaard, NHH, et al.
Publicado: (2002)

Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review
por: Hong, Chris J, et al.
Publicado: (2014)

Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
por: Mullan, Brian, et al.
Publicado: (2011)

Immunodiagnosis and therapeutic immunosuppression in rheumatoid arthritis with ior t1 (anti-CD6) monoclonal antibody
por: Montero, E, et al.
Publicado: (2002)

Allergic diseases of the skin and drug allergies – 2017. Rapid desensitization for delayed reactions to chemotherapy and monoclonal antibodies
por: Vega Castro, Maria Aranzazu, et al.
Publicado: (2013)

EHMTI-0315. AMG 334, the first potent and selective human monoclonal antibody antagonist against the CGRP receptor
por: Xu, C, et al.
Publicado: (2014)

Anti-Ige monoclonal antibody therapy for the treatment of patients with chronic rhinosinusitis: a multi-disciplinary practice review
por: Kilty, Shaun J, et al.
Publicado: (2014)

The application of ACG predictive models to the English population for the purposes of funding allocation
por: Sutch, Stephen, et al.
Publicado: (2008)

Protected Research Information Management Environment (PRIME) provides a secure open source data management option for clinical and scientific research
por: Viangteeravat, Teeradache, et al.
Publicado: (2011)

A platform fed-batch process for various CEMAX(®) producer cell lines
por: Greulich, Benedikt, et al.
Publicado: (2011)

Successful development of novel monoclonal antibodies against HTLV-1 bZIP factor and their applications in studying the pathogenesis of HAM/TSP
por: Saito, Mineki, et al.
Publicado: (2011)

Building Biomedical Imaging and Informatics e-Science platform for translational medical research
por: Zhang, Jianguo, et al.
Publicado: (2012)

Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
por: Baeten, D, et al.
Publicado: (2003)

A new approach of endotoxic testing by using a monoclonal antibody against endotoxin (WN1-222/5) and flow cytometry
por: Staubach, K-H, et al.
Publicado: (2001)

Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

Treatment of severe sepsis in patients with highly elevated IL-6 levels with anti-TNF monoclonal antibody MAK 195F: The Ramses study
por: Reinhart, K
Publicado: (1998)

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
por: Elshahaly, Mohsen, et al.
Publicado: (2013)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
por: Goadsby, P, et al.
Publicado: (2014)

Implementation of a complexity classification system for inpatient rehabilitation facilities for financing purposes - comparing scales
por: Borges, CM, et al.
Publicado: (2009)

Generation of pseudo-CT from a single MRI for PET/MR attenuation correction purposes
por: Monnier, Florian, et al.
Publicado: (2014)

Flexible screening clinics: future options
por: Dyson, SA, et al.
Publicado: (2000)

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
por: Moura, Ivan C, et al.
Publicado: (2011)

Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile
por: Legmann, Rachel, et al.
Publicado: (2011)

Mechanisims of asthma and allergic disease – 1093. A novel human anti-VCAM-1 Monoclonal antibody Ameliorates airway inflammation and remodeling in murine asthma model
por: Lee, Jae-Hyun, et al.
Publicado: (2013)

Disposable bioreactors: from process development to production
por: Polès-Lahille, Aurore, et al.
Publicado: (2011)

Proteins function for anti-senescence and monoclonal proliferation of ATL cells
por: Pornkuna, Ratiorn, et al.
Publicado: (2011)

Biopsy-verified response of severe lupus nephritis to rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to NIH-protocol cyclophosphamide
por: van Vollenhoven, RF, et al.
Publicado: (2002)

Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
por: Konstantinidis, Anastasios
Publicado: (2010)

TAo TAVI + OPCABG: a new hybrid option
por: Brazier, Andrew, et al.
Publicado: (2015)

Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use
por: Sewell, Fiona, et al.
Publicado: (2017)

Teaching breeding planning for a dual-purpose cattle population by a programmed exercise
por: Petersen, PH
Publicado: (1977)

Emergency departments in Denmark with a research responsible consultant expect increased research production
por: Møller, Cecilie Markvard, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ksho1oucrpaimgoeuu79r0qokc